Literature DB >> 15350840

Premature death and age-related cardiac dysfunction in male eNOS-knockout mice.

Wei Li1, Seema Mital, Caroline Ojaimi, Anna Csiszar, Gabor Kaley, Thomas H Hintze.   

Abstract

The aims of our study were to determine mortality, and age- and genotype-related cardiac phenotype in endothelial nitric oxide synthase (NOS) knockout (-/-) and wild-type (+/+) mice. Male and female (-/-) and male and female (+/+) conscious mice were studied at different ages by echocardiography and tail-cuff blood pressure (BP) measurement. Only 50% male (-/-) mice lived longer than 21 months whereas 89% (+/+) mice were still alive after 24 months (P < 0.005). There was little mortality in female mice of either genotype. Both (-/-) and (+/+) male mice have normal cardiac dimensions and function at 5.5 months. However, (-/-) mice developed cardiac dilation and dysfunction at 21 months as evidenced by a significant increase (P < 0.05) in left ventricular (LV) end-diastolic diameter from 2.69 +/- 0.13 to 3.13 +/- 0.09 mm, LV end-systolic diameter from 1.28 +/- 0.11 to 1.86 +/- 0.12 mm, LV end-diastolic cavity volume from 21 +/- 2.8 to 31 +/- 2.5 microl and LV mass from 19 +/- 2.5 to 27 +/- 1.9 mg/10 g and a significant decrease (P < 0.05) in ejection fraction (from 65 +/- 3.3% to 41 +/- 4.6%), shortening fraction (from 53 +/- 2.2% to 41 +/- 3.4%), LV posterior wall thickening (from 27 +/- 2% to 12 +/- 4%) and septum thickening (from 27 +/- 2% to 12 +/- 4%) compared with those at 5.5 months. There was a clear increase in cardiac weight and cardiac dilation by hematoxylin and eosin in male (-/-) mice at 21 months. BP in male (-/-) mice fell with the cardiac dysfunction, whereas female (-/-) mice were hypertensive even at 21 months. The level of mRNA for neuronal NOS and inducible NOS was greater in all females compared to males. These results indicate that male (-/-) mice have a significantly shorter lifespan than (+/+) or female mice, and male (-/-) mice develop cardiac dysfunction with age.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15350840     DOI: 10.1016/j.yjmcc.2004.05.005

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  37 in total

Review 1.  Mechanisms of vascular aging: new perspectives.

Authors:  Zoltan Ungvari; Gabor Kaley; Rafael de Cabo; William E Sonntag; Anna Csiszar
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-06-24       Impact factor: 6.053

2.  Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury.

Authors:  Michael S Forbes; Barbara A Thornhill; Matthew H Park; Robert L Chevalier
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Mechanisms associated to impaired activity of cardiac P-type ATPases in endothelial nitric oxide synthase knockout mice.

Authors:  Daniele C Rezende; Elisa S C Pôças; Humberto Muzi-Filho; Valéria M N Cunha; Afonso Caricati-Neto; Aron Jurkiewicz; François Noël; Luis E M Quintas
Journal:  J Physiol Biochem       Date:  2012-08-09       Impact factor: 4.158

Review 4.  Endothelial dysfunction and angiogenesis impairment in the ageing vasculature.

Authors:  Zoltan Ungvari; Stefano Tarantini; Tamas Kiss; Jonathan D Wren; Cory B Giles; Courtney T Griffin; Walter Lee Murfee; Pal Pacher; Anna Csiszar
Journal:  Nat Rev Cardiol       Date:  2018-09       Impact factor: 32.419

Review 5.  Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease.

Authors:  Anna Csiszar
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 6.  Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease.

Authors:  Xiaohong Liu; Xin Xu; Ruru Shang; Yingjie Chen
Journal:  Nitric Oxide       Date:  2018-06-19       Impact factor: 4.427

7.  Oral nitrite restores age-dependent phenotypes in eNOS-null mice.

Authors:  Margarita Tenopoulou; Paschalis-Thomas Doulias; Kent Nakamoto; Kiara Berrios; Gabriella Zura; Chenxi Li; Michael Faust; Veronika Yakovishina; Perry Evans; Lu Tan; Michael J Bennett; Nathaniel W Snyder; William J Quinn; Joseph A Baur; Dmitriy N Atochin; Paul L Huang; Harry Ischiropoulos
Journal:  JCI Insight       Date:  2018-08-23

Review 8.  Effect of asymmetric dimethylarginine (ADMA) on heart failure development.

Authors:  Xiaoyu Liu; Lei Hou; Dachun Xu; Angela Chen; Liuqing Yang; Yan Zhuang; Yawei Xu; John T Fassett; Yingjie Chen
Journal:  Nitric Oxide       Date:  2016-02-24       Impact factor: 4.427

9.  Aortic valve sclerosis in mice deficient in endothelial nitric oxide synthase.

Authors:  Ramzi N El Accaoui; Sarah T Gould; Georges P Hajj; Yi Chu; Melissa K Davis; Diane C Kraft; Donald D Lund; Robert M Brooks; Hardik Doshi; Kathy A Zimmerman; William Kutschke; Kristi S Anseth; Donald D Heistad; Robert M Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-07       Impact factor: 4.733

10.  Role of NO synthase in the development of Trypanosoma cruzi-induced cardiomyopathy in mice.

Authors:  Jorge L Durand; Shankar Mukherjee; Fernando Commodari; Andrea P De Souza; Dazhi Zhao; Fabiana S Machado; Herbert B Tanowitz; Linda A Jelicks
Journal:  Am J Trop Med Hyg       Date:  2009-05       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.